Figure 3From: Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer TTP probability according to EGFR -191C > A gene polymorphism on the whole population. Median TTP was 2.9 months in CC patients (43 patients, 38 events) vs 2.6 months in CA+AA patients (12 patients, 12 events); Log Rank test: p = 0.050.Back to article page